GlaxoSmithKline PLC — Director's Dealing 2013

Apr 12, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2892C

GlaxoSmithKline PLC

12 April 2013

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the interests of Directors or Persons Discharging Managerial Responsibility in the Ordinary Shares of GlaxoSmithKline plc in respect of the under-mentioned persons arising from the purchase of Ordinary Shares at a price of 1560.192 pence per Ordinary Share on 11 April 2013 as a result of the reinvestment of dividends paid on Ordinary Shares held in the GlaxoSmithKline ShareReward Plan (the Plan).

Sir Andrew Witty	Acquisition of 31 Ordinary Shares
Mr S Dingemans	Acquisition of 6 Ordinary Shares
Mr S M Bicknell	Acquisition of 46 Ordinary Shares
Mr R G Connor	Acquisition of 39 Ordinary Shares
Mr S A Hussain	Acquisition of 8 Ordinary Shares
Mr D S Redfern	Acquisition of 46 Ordinary Shares
Ms C Thomas	Acquisition of 46 Ordinary Shares
Mr P C Thomson	Acquisition of 20 Ordinary Shares
Dr P J T Vallance	Acquisition of 24 Ordinary Shares
Ms E Walmsley	Acquisition of 2 Ordinary Shares
Mrs V A Whyte	Acquisition of 30 Ordinary Shares

The Company and the above-mentioned persons were advised of this information on

12 April 2013.

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

12 April 2013

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSQLLFFXZFFBBB